Agios Pharmaceuticals

Agios Pharmaceuticals concludes initial public offering of 6.7 mln shares

Cancer metabolism specialist Agios Pharmaceuticals closes its initial public offering on Monday.

Read Full Article

Agios prices IPO

Agios Pharmaceuticals, Inc released the details of the company's previously announced IPO.

Read Full Article

Agios says it wants to raise capital through an IPO

Agios Pharmaceuticals Inc. revealed details for its market debut.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics